Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Biocept, Inc.

NASDAQ: BIOCHealthcare / Medical Laboratories & Research / USA
1.01+0.0100+1.00%Vol 833 9991Y Perf -89.25%
Feb 15th, 2019 16:00
BID1.00 ASK1.02
Open1.00 Previous Close1.00
Pre-Market1.00 After-Trading1.02
 - -%  0.01 0.99%
Target Price
5.13 
Analyst Rating
Moderate Buy 1.67
Potencial %
407.92 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★     57.43
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Buy
Price Range Ratio 52wk %
3.01 
Earnings Date
27th Mar 2019

Today's Price Range

0.99001.04

 

52wk Range

0.660012.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-56.84%
3 Months
-34.42%
6 Months
-68.92%
1 Year
-89.25%
3 Years
-99.14%
5 Years
-99.88%

Quotes

Name / TickerPriceChg.Chg.%
BIOC1.010.01001.00
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.40
Current Ratio
2.60
Long Term Debt to Total Capital
0.10
Total Debt to Equity
0.18
Interest Coverage
-104.00
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-194.60
EBIT Margin
-707.20
EBITDA Margin
-684.70
Pre-tax Profit Margin
-3 218.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.56
PS Ratios
2.11
Price to Cash Flow
-
Price to Free Cash Flow
-0.30
Cash Flow Per Share
-11.32
Price to Tangible Book
0.56
Book Value per Share
1.89
Enterprise Value (in ths.)
-2 320
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
383.86
ROE last 12 Months
-383.52
Return on Assets (5Y Avg)
-127.86
ROA last 12 Months
-193.68
Return on Capital (5Y Avg)
-322.33
ROC last 12 Months
-283.82
Return on invested Capital Q
-89.58
Return on invested Capital Y
-492.25
Assets Turnover
0.10
Receivables Turnover
0.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 391
Revenue per Share
0.51
Revenue Growth 3 Years
67.47
Revenue Growth 5 Years
115.58
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.71-2.42-41.52
Q02 2018-3.30-2.7018.18
Q01 2018-2.10-3.30-57.14
Q04 2017-5.71-5.415.25
Q03 2017-5.71-6.01-5.25
Q02 2017-6.01-6.31-4.99
Q01 2017-6.61-6.314.54
Q04 2016-0.34-0.2720.59
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.9323.77Positive
12/2018 QR-1.2218.67Positive
12/2018 FY-9.17-651.64Negative
12/2019 FY-3.1665.08Positive
Next Report Date27th Mar 2019
Estimated EPS Next Report-1.50
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume833 999
Shares Outstanding (in ths.)2 274
Trades Count1 523
Dollar Volume832 018
Avg. Volume3 382 199
Avg. Weekly Volume1 182 017
Avg. Monthly Volume2 873 534
Avg. Quarterly Volume2 320 020

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

23%77%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News